Notably, in December last year, Deep Intelligent Pharma had just announced a US$50 million Series D financing. In less than two months, the company has raised over US$100 million in total.

Claude Sonnet 4.6 beats Opus in agentic tasks, adds 1 million context, and excels in finance and automation, all at one-fifth ...

Research findings are available online in the journal Nature Metabolism. The original story “ Sweating may naturally suppress ...

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can eavesdrop on the hidden electrical dialogues unfolding inside miniature, lab-grown ...

Pope Leo XIV seems to know the issue of Artificial Intelligence (AI) is more than a barroom debate, as the new technology continues to grow at an exponential rate.

AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60 mill ...

Brain tumors do not just invade healthy tissue. They also physically squeeze it, and that mechanical compression may be enough to trigger neuron death in the surrounding brain. Two peer-reviewed ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

A detailed annotation of anatomical brain structures (some novel) of the spider Uloborus diversus is provided based on a ...